genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Videos
Webinars
eBooks
Podcasts
Events
New Products
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
He Jiankui Fired in Wake of CRISPR Babies Investigation
Rare and Neglected Diseases
Orchard Therapeutics Plans 3 Approval Submissions, In-House Manufacturing by 2021
GWAS
Genetic Influences on Body Fat Distribution in Men and Women Identified
GWAS
Skin Color Evolution Painted in New Light
News
Tailoring Specific Therapies for Strokes and Seizures
Insights
Insights
Literature Review: Advanced Biologic Therapies and Advanced Biologics Manufacturing
Insights
Top 10 Global Biopharma IPOs of 2018
January 2019 Vol. 39 No. 1
All Aboard the Genome Express
January 2019 Vol. 39 No. 1
Advancing Precision Medicine Using Cloud-Based Informatics
January 2019 Vol. 39 No. 1
Taking Aim at Target ID and Validation
A-Lists
Insights
Top 10 Global Biopharma IPOs of 2018
A-Lists
5 Biopharma Trends to Watch in 2019
A-Lists
Top 10 RNA-Based Biopharmas of 2018
Insights
Top 10 Molecular Millionaires of 2018
A-Lists
Top 10 Pharma Companies of 2018
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
He Jiankui Fired in Wake of CRISPR Babies Investigation
Rare and Neglected Diseases
Orchard Therapeutics Plans 3 Approval Submissions, In-House Manufacturing by 2021
News
Venom Goes to Bat as Novel Medical Treatment
News
BMS Buyout Not Stopping Celgene from Launching Cancer Collaborations with Kyn,…
Magazine
January 2019 Vol. 39 No. 1
All Aboard the Genome Express
January 2019 Vol. 39 No. 1
Advancing Precision Medicine Using Cloud-Based Informatics
January 2019 Vol. 39 No. 1
Taking Aim at Target ID and Validation
January 2019 Vol. 39 No. 1
CRISPR’s China Crisis
January 2019 Vol. 39 No. 1
PATH: New Organization Fostering AI, Automation and Healthcare
Resources
All
Videos
Webinars
eBooks
Podcasts
Events
New Products
Best of the Web
Best Apps
BioPerspectives
Events
AACR Annual Meeting
Events
Circulating Biomarkers World Congress
Events
Bio Europe Spring
Events
Phar-East
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Home
Rare and Neglected Diseases
Rare and Neglected Diseases
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Rare and Neglected Diseases
Orchard Therapeutics Plans 3 Approval Submissions, In-House Manufacturing by 2021
Rare and Neglected Diseases
Customer Insights: Roivant Scales up Bioprocesses through a CDMO
Rare and Neglected Diseases
Editas Wins FDA Approval for IND of CRISPR Treatment for LCA10
Rare and Neglected Diseases
Shire Licenses Rare Liver Disease Candidates to $120M Startup Mirum
Rare and Neglected Diseases
Ophthotech Expands Eye Disease Pipelines of Small Molecule, Gene Therapy Candidates
Rare and Neglected Diseases
FDA Approves Alnylam’s Onpattro for Polyneuropathy of hATTR Amyloidosis
Rare and Neglected Diseases
Chiesi Gains U.S. Rights to Protalix’ Phase III Fabry Disease Candidate...
Rare and Neglected Diseases
Rare Disease “Hub” Draws Support from Drug Developers
Rare and Neglected Diseases
Six IPOs Raising More than a Half-Billion This Week
Rare and Neglected Diseases
Shire, Takeda Come to Terms on $62B Acquisition Deal
Rare and Neglected Diseases
GSK Hands Off Rare Disease Gene Therapy Portfolio to Orchard Therapeutics
Rare and Neglected Diseases
Alexion to Acquire Wilson Therapeutics for $855M
Rare and Neglected Diseases
Solid Recommits to DMD Gene Therapy on Clinical Hold, as Stock...
Rare and Neglected Diseases
PhaseBio Wins $2.8M SBIR Grant to Advance Lead Candidate
Rare and Neglected Diseases
Redosable Gene-Therapy Developer Generation Bio Wins $100M Series B Financing
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
